Vardhini S Kirthivas

Vardhini S Kirthivas is a seasoned professional with extensive experience in regulatory affairs and project delivery within the medical devices and diagnostics sectors. Currently serving as Group Lead - Regulatory CMC for Oncology and Rare Diseases at Pfizer since August 2023, Vardhini previously held senior leadership roles at Freyr Solutions, where responsibilities included overseeing global project delivery and managing regulatory submissions for medical devices and in-vitro diagnostics. With a career spanning over two decades, Vardhini has also contributed as an Associate Vice President at HCL Technologies and held various positions in esteemed companies such as Glenmark Pharmaceuticals and Sandoz Private Limited. Vardhini's educational background includes a Bachelor of Pharmacy from Birla Institute of Technology and Science and ongoing studies for a Master of Technology in Quality Management.